Gene	0	4	O
transfer	5	13	O
of	14	16	O
naked	17	22	O
DNA	23	26	O
encoding	27	35	O
for	36	39	O
three	40	45	O
isoforms	46	54	O
of	55	57	O
vascular	58	66	B-Gene_or_gene_product
endothelial	67	78	I-Gene_or_gene_product
growth	79	85	I-Gene_or_gene_product
factor	86	92	I-Gene_or_gene_product
stimulates	93	103	O
collateral	104	114	B-Multi-tissue_structure
development	115	126	O
in	127	129	O
vivo	130	134	O
.	134	135	O

Vascular	137	145	B-Gene_or_gene_product
endothelial	146	157	I-Gene_or_gene_product
growth	158	164	I-Gene_or_gene_product
factor	165	171	I-Gene_or_gene_product
(	172	173	O
VEGF	173	177	B-Gene_or_gene_product
)	177	178	O
is	179	181	O
a	182	183	O
naturally	184	193	O
secreted	194	202	O
endothelial	203	214	B-Cell
cell	215	219	I-Cell
-	219	220	O
specific	220	228	O
mitogen	229	236	O
.	236	237	O

We	238	240	O
investigated	241	253	O
the	254	257	O
hypothesis	258	268	O
that	269	273	O
naked	274	279	O
DNA	280	283	O
encoding	284	292	O
for	293	296	O
VEGF	297	301	B-Gene_or_gene_product
could	302	307	O
be	308	310	O
used	311	315	O
in	316	318	O
a	319	320	O
strategy	321	329	O
of	330	332	O
arterial	333	341	O
gene	342	346	O
therapy	347	354	O
to	355	357	O
stimulate	358	367	O
collateral	368	378	B-Multi-tissue_structure
artery	379	385	I-Multi-tissue_structure
development	386	397	O
.	397	398	O

Plasmid	399	406	O
DNA	407	410	O
encoding	411	419	O
each	420	424	O
of	425	427	O
the	428	431	O
three	432	437	O
principal	438	447	O
human	448	453	B-Organism
VEGF	454	458	B-Gene_or_gene_product
isoforms	459	467	O
(	468	469	O
phVEGF121	469	478	B-Gene_or_gene_product
,	478	479	O
phVEGF165	480	489	B-Gene_or_gene_product
,	489	490	O
or	491	493	O
phVEGF189	494	503	B-Gene_or_gene_product
)	503	504	O
was	505	508	O
applied	509	516	O
to	517	519	O
the	520	523	O
hydrogel	524	532	O
polymer	533	540	O
coating	541	548	O
of	549	551	O
an	552	554	O
angioplasty	555	566	O
balloon	567	574	O
and	575	578	O
delivered	579	588	O
percutaneously	589	603	O
to	604	606	O
one	607	610	O
iliac	611	616	B-Multi-tissue_structure
artery	617	623	I-Multi-tissue_structure
of	624	626	O
rabbits	627	634	B-Organism
with	635	639	O
operatively	640	651	O
induced	652	659	O
hindlimb	660	668	B-Organism_subdivision
ischemia	669	677	O
.	677	678	O

Compared	679	687	O
with	688	692	O
control	693	700	O
animals	701	708	O
transfected	709	720	O
with	721	725	O
LacZ	726	730	B-Gene_or_gene_product
,	730	731	O
site	732	736	O
-	736	737	O
specific	737	745	O
transfection	746	758	O
of	759	761	O
phVEGF	762	768	B-Gene_or_gene_product
resulted	769	777	O
in	778	780	O
augmented	781	790	O
collateral	791	801	B-Multi-tissue_structure
vessel	802	808	I-Multi-tissue_structure
development	809	820	O
documented	821	831	O
by	832	834	O
serial	835	841	O
angiography	842	853	O
,	853	854	O
and	855	858	O
improvement	859	870	O
in	871	873	O
calf	874	878	B-Organism
blood	879	884	B-Organism_substance
pressure	885	893	O
ratio	894	899	O
(	900	901	O
ischemic	901	909	B-Organism_subdivision
to	910	912	O
normal	913	919	B-Organism_subdivision
limb	920	924	I-Organism_subdivision
)	924	925	O
,	925	926	O
resting	927	934	O
and	935	938	O
maximum	939	946	O
blood	947	952	B-Organism_substance
flow	953	957	O
,	957	958	O
and	959	962	O
capillary	963	972	B-Tissue
to	973	975	O
myocyte	976	983	B-Cell
ratio	984	989	O
.	989	990	O

Similar	991	998	O
results	999	1006	O
were	1007	1011	O
obtained	1012	1020	O
with	1021	1025	O
phVEGF121	1026	1035	B-Gene_or_gene_product
,	1035	1036	O
phVEGF165	1037	1046	B-Gene_or_gene_product
,	1046	1047	O
and	1048	1051	O
phVEGF189	1052	1061	B-Gene_or_gene_product
,	1061	1062	O
which	1063	1068	O
suggests	1069	1077	O
that	1078	1082	O
these	1083	1088	O
isoforms	1089	1097	O
are	1098	1101	O
biologically	1102	1114	O
equivalent	1115	1125	O
with	1126	1130	O
respect	1131	1138	O
to	1139	1141	O
in	1142	1144	O
vivo	1145	1149	O
angiogenesis	1150	1162	O
.	1162	1163	O

The	1164	1167	O
fact	1168	1172	O
that	1173	1177	O
viral	1178	1183	O
or	1184	1186	O
other	1187	1192	O
adjunctive	1193	1203	O
vectors	1204	1211	O
were	1212	1216	O
not	1217	1220	O
required	1221	1229	O
further	1230	1237	O
suggests	1238	1246	O
that	1247	1251	O
secreted	1252	1260	O
gene	1261	1265	O
products	1266	1274	O
may	1275	1278	O
have	1279	1283	O
potential	1284	1293	O
therapeutic	1294	1305	O
utility	1306	1313	O
even	1314	1318	O
when	1319	1323	O
the	1324	1327	O
number	1328	1334	O
of	1335	1337	O
successfully	1338	1350	O
transfected	1351	1362	O
cells	1363	1368	B-Cell
remains	1369	1376	O
low	1377	1380	O
.	1380	1381	O

Arterial	1382	1390	O
gene	1391	1395	O
transfer	1396	1404	O
of	1405	1407	O
naked	1408	1413	O
DNA	1414	1417	O
encoding	1418	1426	O
for	1427	1430	O
a	1431	1432	O
secreted	1433	1441	O
angiogenic	1442	1452	O
cytokine	1453	1461	O
,	1461	1462	O
thus	1463	1467	O
,	1467	1468	O
represents	1469	1479	O
a	1480	1481	O
potential	1482	1491	O
alternative	1492	1503	O
to	1504	1506	O
recombinant	1507	1518	O
protein	1519	1526	O
administration	1527	1541	O
for	1542	1545	O
stimulating	1546	1557	O
collateral	1558	1568	B-Multi-tissue_structure
vessel	1569	1575	I-Multi-tissue_structure
development	1576	1587	O
.	1587	1588	O

